Ellen Kilger
Surname | Kilger |
First name | Ellen |
Nationality | German |
Present position and title | Science Management, Dr. rer. nat. |
Business address
Institute for Ophthalmic Research
University of Tübingen
Elfriede-Aulhorn-Strasse 7
D-72076 Tübingen,
Germany
Phone: +49 (0)7071 29-84947
Fax: +49 (0)7071 29-5777
E-mail: ellen.kilger@uni-tuebingen.de
Academic Education
Year | Degree | University | Field of study |
---|---|---|---|
2014 | Journalist | Freie Journalistenschule (FJS) Berlin | Journalism, PR |
1998 | Dr. rer. nat. | Ludwig-Maximilians-Universität (LMU) Munich | Biochemistry |
1994 | Diploma | Ludwig-Maximilians-Universität (LMU) Munich | Biology |
Professional Experience
Period | Institution | Position | Discipline |
---|---|---|---|
2016 - present | University of Tübingen, Institute for Ophthalmic Research | Science Management | Ophthalmology
|
2011 - present | Freelance | Journalist and Photographer | Science, Biology, Medicine, Travel, Event |
2003 - 2011 | University of Tübingen, Hertie Institute for Clinical Brain Research | Group leader | Cell biology of Neurological Diseases, Alzheimer Research |
1999 - 2003 | Boehringer Ingelheim Pharma KG, Ingelheim und Biberach/Riss | Postdoc | Alzheimer Research, Genomics |
1998 - 1999 | Institute for Clinical Molecular Biology and Tumor Genetics at GSF-National Research Center for Environment and Health in Munich | Postdoc | Viral Vectors, Epstein-Barr-Virus production in cell lines |
1995 - 1998 | Institute for Clinical Molecular Biology and Tumor Genetics at GSF-National Research Center for Environment and Health in Munich | PhD student | Epstein-Barr-Virus, Cell Biology, Tumor Virology |
Awards
2011 | Award “Paper of the week” by the Journal of Biological Chemistry for J Biol Chem. 2011 Oct 28;286(43):37446-57. DOI: 10.1074/jbc.M111.288373 |
1999 | Award from GSF Research Center Munich for best doctoral thesis in biology |
Publications
- Merle, D. A., Provenzano, F., Jarboui, M. A., Kilger, E., Clark, S. J., Deleidi, M., Armento, A., and Ueffing, M. (2021) mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells. Antioxidants (Basel) 10
- Armento, A., Schmidt, T. L., Sonntag, I., Merle, D. A., Jarboui, M. A., Kilger, E., Clark, S. J., and Ueffing, M. (2021) CFH Loss in Human RPE Cells Leads to Inflammation and Complement System Dysregulation via the NF-kappaB Pathway. Int J Mol Sci 22
- Armento, A., Murali, A., Marzi, J., Almansa-Garcia, A. C., Arango-Gonzalez, B., Kilger, E., Clark, S. J., Schenke-Layland, K., Ramlogan-Steel, C. A., Steel, J. C., and Ueffing, M. (2021) Complement Factor H Loss in RPE Cells Causes Retinal Degeneration in a Human RPE-Porcine Retinal Explant Co-Culture Model. Biomolecules 11
- Armento, A., Honisch, S., Panagiotakopoulou, V., Sonntag, I., Jacob, A., Bolz, S., Kilger, E., Deleidi, M., Clark, S., and Ueffing, M. (2020) Loss of Complement Factor H impairs antioxidant capacity and energy metabolism of human RPE cells. Sci Rep 10, 10320
- Kilger, E., Buehler, A., Woelfing, H., Kumar, S., Kaeser, S. A., Nagarathinam, A., Walter, J., Jucker, M., and Coomaraswamy, J. (2011) BRI2 protein regulates beta-amyloid degradation by increasing levels of secreted insulin-degrading enzyme (IDE). J Biol Chem 286, 37446-37457
- Coomaraswamy, J., Kilger, E., Wolfing, H., Schafer, C., Kaeser, S. A., Wegenast-Braun, B. M., Hefendehl, J. K., Wolburg, H., Mazzella, M., Ghiso, J., Goedert, M., Akiyama, H., Garcia-Sierra, F., Wolfer, D. P., Mathews, P. M., and Jucker, M. (2010) Modeling familial Danish dementia in mice supports the concept of the amyloid hypothesis of Alzheimer's disease. Proc Natl Acad Sci U S A 107, 7969-7974
- Kaeser, S. A., Herzig, M. C., Coomaraswamy, J., Kilger, E., Selenica, M. L., Winkler, D. T., Staufenbiel, M., Levy, E., Grubb, A., and Jucker, M. (2007) Cystatin C modulates cerebral beta-amyloidosis. Nature genetics 39, 1437-1439
- Hamid, R., Kilger, E., Willem, M., Vassallo, N., Kostka, M., Bornhovd, C., Reichert, A. S., Kretzschmar, H. A., Haass, C., and Herms, J. (2007) Amyloid precursor protein intracellular domain modulates cellular calcium homeostasis and ATP content. J Neurochem 102, 1264-1275
- Eisele, Y. S., Baumann, M., Klebl, B., Nordhammer, C., Jucker, M., and Kilger, E. (2007) Gleevec increases levels of the amyloid precursor protein intracellular domain and of the amyloid-beta degrading enzyme neprilysin. Molecular biology of the cell 18, 3591-3600
- Meyer-Luehmann, M., Coomaraswamy, J., Bolmont, T., Kaeser, S., Schaefer, C., Kilger, E., Neuenschwander, A., Abramowski, D., Frey, P., Jaton, A. L., Vigouret, J. M., Paganetti, P., Walsh, D. M., Mathews, P. M., Ghiso, J., Staufenbiel, M., Walker, L. C., and Jucker, M. (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313, 1781-1784
- Dirmeier, U., Hoffmann, R., Kilger, E., Schultheiss, U., Briseno, C., Gires, O., Kieser, A., Eick, D., Sugden, B., and Hammerschmidt, W. (2005) Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene 24, 1711-1717
- Dirmeier, U., Neuhierl, B., Kilger, E., Reisbach, G., Sandberg, M. L., and Hammerschmidt, W. (2003) Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus. Cancer Res 63, 2982-2989
- Kilger, E., and Hammerschmidt, W. (2001) Genetic analysis and gene expression with mini-Epstein-Barr virus plasmids. Methods Mol Biol 174, 23-35
- Kilger, E., Pecher, G., Schwenk, A., and Hammerschmidt, W. (1999) Expression of mucin (MUC-1) from a mini-Epstein-Barr virus in immortalized B-cells to generate tumor antigen specific cytotoxic T cells. J Gene Med 1, 84-92
- Gires, O., Kohlhuber, F., Kilger, E., Baumann, M., Kieser, A., Kaiser, C., Zeidler, R., Scheffer, B., Ueffing, M., and Hammerschmidt, W. (1999) Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. EMBO J 18, 3064-3073
- Kilger, E., Kieser, A., Baumann, M., and Hammerschmidt, W. (1998) Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J 17, 1700-1709
- Kieser, A., Kilger, E., Gires, O., Ueffing, M., Kolch, W., and Hammerschmidt, W. (1997) Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J 16, 6478-6485